A Phase I, Open-Label Study of the Safety, Tolerability and Pharmacokinetics of GW572016 in Combination With Docetaxel (Taxotere)
Latest Information Update: 29 Aug 2023
At a glance
- Drugs Lapatinib (Primary) ; Docetaxel
- Indications Breast cancer; Solid tumours
- Focus Adverse reactions
- Sponsors GSK
- 08 Dec 2017 New trial record